Video -

Attana on Today in America

Attana is featured in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to “Improving Diagnostic Outcomes through Biosensor Technology” as part of the show’s “Medical Minutes” series. In the clip we find out why biological relevance is important and how it is possible to shorten the time between research initiation and new drug on the market.
  • License: Creative Commons Attribution
    With a Creative Commons license, you keep your copyright but allow people to copy and distribute your work, provided they give you credit. You permit others to copy, distribute, display and perform the work, as well as make derivative works based on it.
  • File format: .mpg
  • Length: 5:00
Download

Subjects

  • Medical research

Categories

  • today in america
  • attana
  • terry bradshaw
  • biosensor

Related content

Biosensor- Attana Cell 200, label free, real time kinetics on cells

Revolutionary Swedish invention can potentially improve drug development! Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.

Attana AB and Layerlab AB sign global distribution agreement

Attana and Layerlab announced today that they have signed a global distribution agreement under which Attana will distribute memLAYER ™ for utilization together with Attana’s QCM biosensors. With biosensor users in mind, both Attana and Layerlab can now offer the market new and improved application methods.

Tecan and Attana extend distribution agreement

Stockholm, Sweden, October 11, 2011- Tecan and Attana AB have announced an extended distribution agreement under which Tecan will distribute Attana's label-free biosensor instruments and quartz crystal microbalance (QCM) assay technology in Europe.

Global customer proximity for Swedish biotech company Attana AB

“Global customer proximity is Attana’s next step towards assuring that our customers receive highest quality support and service through established distributors,” commented Teodor Aastrup, CEO and founder of Attana.

The combination between biochemical and cell based assay- Attana appears in International Trade News

Long before pharmaceutical substances are tried on animals or human beings, they are carefully tested in simulated environments. Attana's biosensors characterize molecular interactions exactly as they would occur in the human body, the company offers its clients relevant information before further tests are carried out.

A New Generation of Cell-Biosensors targeting Cancer

Read the latest article in IPT (Innovations in Pharmaceutical Technology) about the new generation cell-biosensors that enables studies in a more relevant cellular environment to better understand drug-cell interactions for development of new pharmaceuticals. A model like this using bio-sensors could significantly reduce the costs and time-scales involved in the development of the next generation

Tecan Journal- corporate news!

Find out latest news, events and collaborations from Tecan- read the interview with Attana's Sales and Marketing Manager, Gabriela Suhoschi about Attana's collaboration with Tecan's on page 5!

Attana appears in Swedish Life Science

"Swedish Life Science is a comprehensive introduction to an industry that employs some 40,000 people in Sweden, accounts for 20 per cent of Swedish net export worth over over SEK 40 billion, and is fast becoming a cornerstone of the national economy."

Find out: Why bridge the existing gap between biochemical and cell based assays?

One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.

A film crew, cameras and biosensors!

Recently a film crew visited the Attana office to prepare our participation on Terry Bradshaw’s “Today in America” show. Their research team had heard about our ground breaking cell based biosensor and asked us to participate on the show. The days before the filming were filled with intense preparation, and consequently on the day of shooting everything went smoothly..

Is biotech as hot as fashion?

Promoting our biosensors all over the world involve fun travelling performing LIVE demos, seminars, customer meetings and training. Coming back from one of our longer trips recently we discovered that the biotech field is just as hot as the fashion industry.